Infliximab treatment failure in a case of cutaneous Crohn's disease

Your saved search

Your RSS Feed

Case Reports

. 2005 Nov;53(5):903-4.

doi: 10.1016/j.jaad.2005.04.081.

Case Reports

Deborah J Yang et al. J Am Acad Dermatol. 2005 Nov.

. 2005 Nov;53(5):903-4.

doi: 10.1016/j.jaad.2005.04.081.

No abstract available

Similar articles

Successful treatment of therapy-resistant metastatic Crohn's disease with infliximab.
Rispo A, Lembo G, Insabato L, Cozzolino A, Pesce G, Castiglione F. Rispo A, et al. Br J Dermatol. 2004 May;150(5):1045-6. doi: 10.1111/j.1365-2133.2004.05958.x. Br J Dermatol. 2004. PMID: 15149534 No abstract available.
Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
Kouklakis G, Moschos J, Leontiadis GI, Kadis S, Mpoumponaris A, Molyvas E, Minopoulos GI. Kouklakis G, et al. Rom J Gastroenterol. 2005 Dec;14(4):401-3. Rom J Gastroenterol. 2005. PMID: 16400359
An unusual cutaneous manifestation of Crohn's disease.
Weiser JA, Markowitz DM, Husain S, Grossman ME. Weiser JA, et al. Skinmed. 2011 May-Jun;9(3):196-8. Skinmed. 2011. PMID: 21675504
Off-label uses and side effects of infliximab.
Scheinfeld N. Scheinfeld N. J Drugs Dermatol. 2004 May-Jun;3(3):273-84. J Drugs Dermatol. 2004. PMID: 15176162 Review.
[Metastatic Crohn's disease].
Romero Gutiérrez M, Alcántara Torres M, Muñoz Rosas C, Gómez Moreno AZ, Guardiola Arévalo A, Rodríguez Merlo R, Carrobles Jiménez JM. Romero Gutiérrez M, et al. Gastroenterol Hepatol. 2010 Jun-Jul;33(6):440-4. doi: 10.1016/j.gastrohep.2010.03.007. Epub 2010 May 27. Gastroenterol Hepatol. 2010. PMID: 20537428 Review. Spanish.